title: Dermatomyositis associated with ovarian transitional cell carcinoma.
authors.forename: J H
authors.initials: JH
authors.lastname: Hagman
authors.forename: L
authors.initials: L
authors.lastname: Bianchi
authors.forename: E
authors.initials: E
authors.lastname: Campione
authors.forename: A P
authors.initials: AP
authors.lastname: Vidolin
authors.forename: S
authors.initials: S
authors.lastname: Chimenti
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000150:complications* / Q000473:pathology / Q000601:surgery; D003882:Dermatomyositis / Q000209:etiology* / Q000473:pathology; D004487:Edema / Q000209:etiology; D005143:Eyelids / Q000473:pathology; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage; D008875:Middle Aged; D018908:Muscle Weakness / Q000209:etiology; D018482:Muscle, Skeletal / Q000473:pathology; D009362:Neoplasm Metastasis; D009852:Omentum / Q000473:pathology; D010051:Ovarian Neoplasms / Q000150:complications* / Q000473:pathology / Q000601:surgery
chemical_list: D016756:Immunoglobulins, Intravenous